Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Cell entry mechanisms of SARS-CoV-2
2020 Standout
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
2015
Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction
2020 Standout
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
2020 Science
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
2020 Standout
Microbiota in health and diseases
2022 Standout
Coronavirus biology and replication: implications for SARS-CoV-2
2020 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – Role of gut microbiota dysbiosis
2020
Oxidative stress, aging, and diseases
2018 Standout
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
2020 Standout
Characteristics of SARS-CoV-2 and COVID-19
2020 Standout
SARS and MERS: recent insights into emerging coronaviruses
2016 Standout
Role of ROS and RNS Sources in Physiological and Pathological Conditions
2016 Standout
Cytochrome P450: taming a wild type enzyme
2011 StandoutNobel
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Molecular determinants of drug–receptor binding kinetics
2013
Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure
2006
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment
2004
NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
2018 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Ranolazine for chronic stable angina
2008
Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts
2006
Drugs acting on renin angiotensin system and use in ill patients with COVID-19
2020
International Union of Basic and Clinical Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors
2013
Contribution of Protons to Post‐Ischemic Na+ and Ca2+ Overload and Left Ventricular Mechanical Dysfunction
2006
Cellular Fatty Acid Metabolism and Cancer
2013 Standout
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
2020
Generation of the Human Metabolite Piceatannol from the Anticancer-Preventive Agent Resveratrol by Bacterial Cytochrome P450 BM3
2009
Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension
2014 Nobel
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine
2006
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
2020 StandoutNature
Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction
2009
Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19
2020
A Comparison between Ranolazine and CVT-4325, a Novel Inhibitor of Fatty Acid Oxidation, on Cardiac Metabolism and Left Ventricular Function in Rat Isolated Perfused Heart during Ischemia and Reperfusion
2007
Microbiota Modulation of the Gut-Lung Axis in COVID-19
2021 Standout
Improved Left Ventricular Function and Reduced Necrosis after Myocardial Ischemia/Reperfusion in Rabbits Treated with Ranolazine, an Inhibitor of the Late Sodium Channel
2006
Trimetazidine Normalizes Postischemic Function of Hypertrophied Rat Hearts
2005
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
2020 Standout
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
2020 Standout
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
2016 StandoutNobel
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)
2013
The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection
2020
The Limits and Promise of Environmental Conflict Prevention: The Case of the GEF
1998
Interrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatments
2014
Narcotic analgetics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques
1977 Standout
COVID-19 and Cardiovascular Disease
2020
Ranolazine for the Treatment of Chronic Angina and Potential Use in Other Cardiovascular Conditions
2006
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response
2020
Developing swidden agriculture and the threat of biodiversity loss
1997
Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies
2015
Ranolazine in patients with coronary artery disease
2007
Metabolic Modulators for Chronic Cardiac Ischemia
2005
Detection of SARS-CoV-2 in Different Types of Clinical Specimens
2020 Standout
Metabolic Mechanisms in Heart Failure
2007
Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective
2018 Standout
Role and mechanism of angiotensin‐converting enzyme 2 in acute lung injury in coronavirus disease 2019
2020
Systems biology of oxygen homeostasis
2017 StandoutNobel
Structure and floristics of an old secondary rain forest in Central Kalimantan, Indonesia, and a comparison with adjacent primary forest
2004 Standout
A Diamond Curse?
2005 Standout
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Modification of escape from noxious stimuli after bulbar reticular formation lesions
1974
Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia
2020 Standout
Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus
2013
Works of David Fairman being referenced
Small, non-peptide C5a receptor antagonists: Part 2
2008
Progress Curve Analysis of CYP1A2 Inhibition: A More Informative Approach to the Assessment of Mechanism-Based Inactivation?
2007
Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling
2012
Small, non-peptide C5a receptor antagonists: Part 1
2008
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome
2017
Commentary: The New Gef
1994
Unilateral Thalamic Tractotomy for the Relief of Bilateral Pain in Malignant Tumors
1967
The Antianginal Agent Trimetazidine Does Not Exert Its Functional Benefit via Inhibition of Mitochondrial Long-Chain 3-Ketoacyl Coenzyme A Thiolase
2003
Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease
2011